Back
Fate Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
FATE
Fate Therapeutics, Inc.
Last Price:
$1.37
Seasonality Move:
3.56%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FATE is experiencing slight buying pressure.
Fate Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.21 | Buy |
| 20-day SMA: | 1.2 | Buy |
| 50-day SMA: | 1.12 | Buy |
| 200-day SMA: | 1.16 | Buy |
| 8-day EMA: | 1.21 | Buy |
| 20-day EMA: | 0.91 | Buy |
| 50-day EMA: | 0.51 | Buy |
| 200-day EMA: | 0.16 | Buy |
Fate Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 64.88 | Buy |
| Chaikin Money Flow: | 300755 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.09 - 1.27) | Buy |
| Bollinger Bands (100): | (1 - 1.36) | Buy |
Fate Therapeutics, Inc. Technical Analysis
| Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fate Therapeutics, Inc. Stock
Is Fate Therapeutics, Inc. Stock a Buy?
-
Fate Therapeutics, Inc. share price is 1.37 while FATE 8-day simple moving average is 1.21, which is a Buy signal.
-
The stock price of FATE is 1.37 while Fate Therapeutics, Inc. 20-day SMA is 1.20, which makes it a Buy.
-
Fate Therapeutics, Inc. 50-day simple moving average is 1.12 while FATE share price is 1.37, making it a Buy technically.
-
FATE stock price is 1.37 and Fate Therapeutics, Inc. 200-day simple moving average is 1.16, creating a Buy signal.
FATE Technical Analysis vs Fundamental Analysis
Buy
57
Fate Therapeutics, Inc. (FATE)
is a Buy
Is Fate Therapeutics, Inc. a Buy or a Sell?
-
Fate Therapeutics, Inc. stock is rated a BuyThe current Fate Therapeutics, Inc. [FATE] share price is $1.37. The Score for FATE is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Fate Therapeutics, Inc. Stock Info
Market Cap:
158M
Price in USD:
1.37
Share Volume:
1.3M
Fate Therapeutics, Inc. 52-Week Range
52-Week High:
1.94
52-Week Low:
0.66
Buy
57
Fate Therapeutics, Inc. (FATE)
is a Buy
Fate Therapeutics, Inc. Share Price Forecast
-
What is the Fate Therapeutics, Inc. stock price today?The Fate Therapeutics, Inc. stock price is 1.37 USD today.
-
Will FATE stock go up or go down?Fate Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Fate Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fate Therapeutics, Inc. is not overvalued.
Is Fate Therapeutics, Inc. Stock a Buy?
-
Fate Therapeutics, Inc. share price is 1.37 while FATE 8-day exponential moving average is 1.21, which is a Buy signal.
-
The stock price of FATE is 1.37 while Fate Therapeutics, Inc. 20-day EMA is 0.91, which makes it a Buy.
-
Fate Therapeutics, Inc. 50-day exponential moving average is 0.51 while FATE share price is 1.37, making it a Buy technically.
-
FATE stock price is 1.37 and Fate Therapeutics, Inc. 200-day simple moving average is 0.16, creating a Buy signal.
Fundamental Analysis of Fate Therapeutics, Inc.
Is Fate Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.04 per share.
Technical Analysis of Fate Therapeutics, Inc.
Should I short Fate Therapeutics, Inc. stock?
-
FATE Moving Average Covergence Divergence (MACD) indicator is 0.31, suggesting Fate Therapeutics, Inc. is a Buy
-
Fate Therapeutics, Inc. Relative Strength Index (RSI) is 64.88, which suggest Fate Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Fate Therapeutics, Inc. is (1.09 - 1.27), which suggest Fate Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Fate Therapeutics, Inc. is (1 - 1.36), which suggest Fate Therapeutics, Inc. is a Buy
* Fate Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.